Insider Cluster (2 insiders) ·Filed Aug 7, 2026

AMGN

AMGEN INC
NEUTRAL
Impact 2/10
Horizondays Processed1mo ago
Insider cluster: 2 insiders, $1.6M total
Actionable Insight • Neutral

The insider sales are routine and immaterial — no bearish signal. Monitor for any upcoming 8-K or earnings release that could provide context, but this cluster alone does not warrant a trading action.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d ⚠ clustered
AMGN ▼ -5.76% at T+20d
NEUTRAL call ✗ call lost -5.76% · α vs SPY -4.85% · entry $417.20 → $393.17
Next anchor: T+60d in 4w
Latest observation: T+36 -5.42% FF3 residual α
Entry anchored
Aug 7, 05:06 PM ET
via 1-min bar
T+1d
-0.70%
call -0.70% · α -0.38%
$414.30
settled 8w ago
T+5d
+0.52%
call +0.52% · α +0.57%
$419.38
settled 7w ago
T+20d
-5.76%
call -5.76% · α -4.85%
$393.17
settled 28d ago
T+60d
—
call — · α —
—
in 4w

Price Chart

Loading chart...

Executive Summary

Two senior Amgen executives (SVP & CCO and SVP, Human Resources) executed open-market sales totaling $1.63M on August 6, 2026, at ~$402/share. These sales are part of a broader cluster that includes derivative exercises and director grants, but the open-market sales represent a trivial 0.0007% of Amgen's $222B market cap, making them routine and non-informative. Historical calibration on this ticker shows poor predictive performance for past reports, reinforcing that this cluster does not warrant a directional call.

Key Financial Metrics

Direction
selling
Total Value
$1.6M
Insiders
2

Key Facts

  • Two SVP-level executives sold a combined ~3,970 shares open-market on August 6, 2026
  • Total open-market sale value: $1.63M, representing ~0.0007% of $222B market cap
  • Sales coincided with derivative exercises (non-cash) and director grants (non-cash) in the same week
  • No C-suite (CEO/CFO) participation in open-market sales
  • Historical reports on AMGN have a 25% win rate at T+20, suggesting limited predictive value

Financial Impact

Open-market sales of $1.63M, trivial relative to $222B market cap

insider ownership

Risk Factors

  • Insider sales could be misinterpreted as bearish by retail traders
  • No C-suite buying to offset the selling signal

Market Snapshot

Price
$417.06
Volume
100
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
49% bullish (43 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-AMGN-1786410074023
16 reports for AMGN
Performance horizon
83% Hit rate 5 of 6 directional calls best @ T+60▲ +29.13%Jun 3, 2026
Filters
Rows
Reports for AMGN — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
ANALYST-DOWNGRADE
BEARISH ★ 4/10
$382.47 $379.78▲ +0.70%▲ +0.20%$403.04 (−5.38%)
Sep 8, 2026
24d ago
ANALYST-DOWNGRADE
BEARISH ★ 4/10
$393.17 $375.65▲ +4.46%▲ +3.34%$403.04 (−2.51%)
Aug 14, 2026
7w ago
Court Ruling
BULLISH ★ 7/10
$415.21 $439.33▲ +5.81%▲ +7.18%$403.04 (−2.93%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$415.21 $439.33▲ +5.81%▲ +7.18%$403.04 (−2.93%)
Aug 11, 2026
7w ago
Court Ruling
NEUTRAL ★ 3/10
$414.30 $425.28▲ +2.65%▲ +3.05%$403.04 (−2.72%)
Aug 7, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$417.20 $419.38▲ +0.52%▲ +0.57%$403.04 (−3.39%)
Aug 7, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$417.20 $419.38▲ +0.52%▲ +0.57%$403.04 (−3.39%)
Aug 7, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$417.20 $419.38▲ +0.52%▲ +0.57%$403.04 (−3.39%)
Aug 4, 2026
8w ago
GOVT-CONTRACT
NEUTRAL ★ 3/10
$390.02 $414.30▲ +6.23%▲ +6.33%$403.04 (+3.34%)
Jul 31, 2026
9w ago
8-K
BEARISH ★ 5/10
$378.87 $417.20▼ −10.12%▼ −8.09%$403.04 (−6.38%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (65h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 11, 2026